High demands of gloves in US and Europe as record high cases,hospitalizations and testings since December as pandemic is no where near over.Top 4 gloves except Supermax will experience increased orders and higher utilization rate with reduced raw materials cost

PAT around RM500-600millions

Supermax without US and Canada market coming QR profits release mid February will be as low as Top Glove previous QR profits RM180+millions

Today is Hartalega day super bull anticipating good QR announcement next week

Today is Hartalega day super bull anticipating good QR announcement next week

US dollar increase due to US interest rate hike 3-4 times this year will be positive news to exporters like glove companies in Malaysia with higher profits

The major averages fell sharply Tuesday as government bond yields hit Covid-era highs and after Goldman Sachs reported disappointing earnings.

The Dow Jones Industrial Average slipped 543.34 points, or 1.5%, to close at 35,368.47. The S&P 500 fell 1.8% to 4,577.11, and the Nasdaq Composite declined 2.6% to 14,506.90, hitting its lowest level in three months.

The technology-focused Nasdaq sits more than 10% from its most recent high and closed below its 200-day moving average for the first time since April 2020. The small-cap benchmark Russell 2000 slid nearly 3.1%.

Technology stocks declined on Tuesday, continuing their downward trend in 2022 as interest rates rise. Higher rates typically hurt growth pockets of the market that rely on low rates to borrow for investing in innovation. Further, their future earnings look less attractive when rates are spiking.

The major averages fell sharply Tuesday as government bond yields hit Covid-era highs and after Goldman Sachs reported disappointing earnings.

The Dow Jones Industrial Average slipped 543.34 points, or 1.5%, to close at 35,368.47. The S&P 500 fell 1.8% to 4,577.11, and the Nasdaq Composite declined 2.6% to 14,506.90, hitting its lowest level in three months.

The technology-focused Nasdaq sits more than 10% from its most recent high and closed below its 200-day moving average for the first time since April 2020. The small-cap benchmark Russell 2000 slid nearly 3.1%.

Technology stocks declined on Tuesday, continuing their downward trend in 2022 as interest rates rise. Higher rates typically hurt growth pockets of the market that rely on low rates to borrow for investing in innovation. Further, their future earnings look less attractive when rates are spiking.

The major averages fell sharply Tuesday as government bond yields hit Covid-era highs and after Goldman Sachs reported disappointing earnings.

The Dow Jones Industrial Average slipped 543.34 points, or 1.5%, to close at 35,368.47. The S&P 500 fell 1.8% to 4,577.11, and the Nasdaq Composite declined 2.6% to 14,506.90, hitting its lowest level in three months.

The technology-focused Nasdaq sits more than 10% from its most recent high and closed below its 200-day moving average for the first time since April 2020. The small-cap benchmark Russell 2000 slid nearly 3.1%.

Technology stocks declined on Tuesday, continuing their downward trend in 2022 as interest rates rise. Higher rates typically hurt growth pockets of the market that rely on low rates to borrow for investing in innovation. Further, their future earnings look less attractive when rates are spiking.

Already expected Canada government import ban since November just old news... Other top 3 Malaysia glove will benefit and grab Supermax market share in Canada and US

Exporters like glove companies will benefit a lot from US dollar appreciation due to coming US rate hike 3-4 times this year.... Nasdaq tech stocks looking very bearish today will affect Malaysia tech stocks price tomorrow

Top 3 glove companies doing great business in US and Europe since December as Omicron effects causing new record high hospitalizations in US and Europe plus Supermax CBP ban and Chinese glove import tariffs

Top Glove next QR Dec-Feb release mid March will hv improved profits compares to last QR profits RM180+millions as high demands/usage and new record high hospitalizations in US and Europe

Top Glove next QR in mid March will be higher than previous QR profits RM180+millions as very high demands of gloves in US and Europe as record high hospitalizations since December

Supermax is losing entirely all its market share in US and Canada to other top 3 Malaysia glove makers as record high hospitalizations in both countries causing very high demands of nitrile gloves since December

The new report from Britain, which included data on people who had received the AstraZeneca, Pfizer or Moderna shots, confirmed that the vaccines — both the initial two-shot series and booster doses — were less effective and waned faster against Omicron than against Delta.

Among people who received two doses of the AstraZeneca vaccine, a booster with one of the mRNA vaccines, made by Pfizer and Moderna, was 60 percent effective at preventing symptomatic disease two to four weeks after the shot. After 10 weeks, however, the Pfizer booster was just 35 percent effective. The Moderna booster was 45 percent effective at up to nine weeks.

The new report from Britain, which included data on people who had received the AstraZeneca, Pfizer or Moderna shots, confirmed that the vaccines — both the initial two-shot series and booster doses — were less effective and waned faster against Omicron than against Delta.

Among people who received two doses of the AstraZeneca vaccine, a booster with one of the mRNA vaccines, made by Pfizer and Moderna, was 60 percent effective at preventing symptomatic disease two to four weeks after the shot. After 10 weeks, however, the Pfizer booster was just 35 percent effective. The Moderna booster was 45 percent effective at up to nine weeks.

The new report from Britain, which included data on people who had received the AstraZeneca, Pfizer or Moderna shots, confirmed that the vaccines — both the initial two-shot series and booster doses — were less effective and waned faster against Omicron than against Delta.

Among people who received two doses of the AstraZeneca vaccine, a booster with one of the mRNA vaccines, made by Pfizer and Moderna, was 60 percent effective at preventing symptomatic disease two to four weeks after the shot. After 10 weeks, however, the Pfizer booster was just 35 percent effective. The Moderna booster was 45 percent effective at up to nine weeks.

Top Glove shares looking for price recovery next week as HK IPO price fixing coming next 1-2 months...Omicron variant causing new record high hospitalizations in US higher than before vaccines are available end 2020

Top Glove large share buy back by its chairman is positive news for glove stocks share price recovery next week as investors selling down tech stocks and IBs short selling tech stocks

Today heavy selling down tech stocks in Malaysia as Nasdaq index continues under selling pressure as interest rate hike in US coming soon....Glove stocks unlikely to drop much compares to tech stocks coming few weeks as high nitrile gloves demands and usage in US and Europe

Top Glove next QR profits released mid March will be higher than previous profits RM180millions as higher demands and lower raw materials cost

Short sellers every day large share buy back Top Glove shares down to 2.17% from previous high 2.75% last week.

EPF next month February will announce good dividends around 5.5%

Waiting for ASP to normalize as early as 1st quarter but nitrile gloves demands and usage definitely increasing especially in US and Europe

Top 3 glove companies will still be making good profits and will not be loss making companies as medical nitrile glove demands and usage still very high in US and Europe as this pandemic will not end so easily.

No need ask why keep falling if can't endure losses just sell the shares..Lol

Mrkingstock Y keep falling
UlarSawa
Ryan83
will answer
13/01/2022 11:53 AM

Now Omicron variant causing new record high hospitalizations in US and Europe will cause very high demand of medical gloves especially nitrile gloves...Even without pandemic glove usage growth at least 10% per year and Malaysia glove companies still making good profits with billions of cash balances after 2 years of pandemic Covid-19

Top 3 glove companies will have larger glove exports and much higher market share in US coming QR release as US has ban Supermax since October and China glove under import tariffs since December.

Top Glove next QR profits should be more than previous QR profits RM180+millions as increasing demands and lowering raw material costs

Last minute Top Glove share price push up closing 2.41

HONG KONG—With Covid-19 flaring up across China, major manufacturers are shutting factories, ports are clogging up and workers are in short supply as officials impose city lockdowns and mass testing on a scale unseen in nearly two years.

The prospect of continued disruptions in the world’s second-largest economy, which has a zero-tolerance strategy for combating the pandemic, is heightening fears that the disruptions will ripple through the global economy. Already, companies including memory-chip maker Samsung Electronics Co., German auto maker Volkswagen AG and a textiles company that supplies Nike Inc. and Adidas AG are suffering production hitches.

Since late December, officials have taken measures to counter Covid-19 outbreaks in several Chinese cities, including the eastern port of Tianjin, Xi’an in central China, and the southern technology hub of Shenzhen. The world’s third-busiest container port of Ningbo-Zhoushan, near Shanghai, risks worsening backlogs from restrictions on trucks and warehouse operations after more than two dozen Covid-19 cases were confirmed in the surrounding area.

HONG KONG—With Covid-19 flaring up across China, major manufacturers are shutting factories, ports are clogging up and workers are in short supply as officials impose city lockdowns and mass testing on a scale unseen in nearly two years.

The prospect of continued disruptions in the world’s second-largest economy, which has a zero-tolerance strategy for combating the pandemic, is heightening fears that the disruptions will ripple through the global economy. Already, companies including memory-chip maker Samsung Electronics Co., German auto maker Volkswagen AG and a textiles company that supplies Nike Inc. and Adidas AG are suffering production hitches.

Since late December, officials have taken measures to counter Covid-19 outbreaks in several Chinese cities, including the eastern port of Tianjin, Xi’an in central China, and the southern technology hub of Shenzhen. The world’s third-busiest container port of Ningbo-Zhoushan, near Shanghai, risks worsening backlogs from restrictions on trucks and warehouse operations after more than two dozen Covid-19 cases were confirmed in the surrounding area.

HONG KONG—With Covid-19 flaring up across China, major manufacturers are shutting factories, ports are clogging up and workers are in short supply as officials impose city lockdowns and mass testing on a scale unseen in nearly two years.

The prospect of continued disruptions in the world’s second-largest economy, which has a zero-tolerance strategy for combating the pandemic, is heightening fears that the disruptions will ripple through the global economy. Already, companies including memory-chip maker Samsung Electronics Co., German auto maker Volkswagen AG and a textiles company that supplies Nike Inc. and Adidas AG are suffering production hitches.

Since late December, officials have taken measures to counter Covid-19 outbreaks in several Chinese cities, including the eastern port of Tianjin, Xi’an in central China, and the southern technology hub of Shenzhen. The world’s third-busiest container port of Ningbo-Zhoushan, near Shanghai, risks worsening backlogs from restrictions on trucks and warehouse operations after more than two dozen Covid-19 cases were confirmed in the surrounding area.

HONG KONG—With Covid-19 flaring up across China, major manufacturers are shutting factories, ports are clogging up and workers are in short supply as officials impose city lockdowns and mass testing on a scale unseen in nearly two years.

The prospect of continued disruptions in the world’s second-largest economy, which has a zero-tolerance strategy for combating the pandemic, is heightening fears that the disruptions will ripple through the global economy. Already, companies including memory-chip maker Samsung Electronics Co., German auto maker Volkswagen AG and a textiles company that supplies Nike Inc. and Adidas AG are suffering production hitches.

Since late December, officials have taken measures to counter Covid-19 outbreaks in several Chinese cities, including the eastern port of Tianjin, Xi’an in central China, and the southern technology hub of Shenzhen. The world’s third-busiest container port of Ningbo-Zhoushan, near Shanghai, risks worsening backlogs from restrictions on trucks and warehouse operations after more than two dozen Covid-19 cases were confirmed in the surrounding area.

Needs to break 2.50 for further upside momentum today

The United States surpassed its record for covid-19 hospitalizations on Tuesday, with no end in sight to skyrocketing case loads, falling staff levels and the struggles of a medical system trying to provide care amid an unprecedented surge of the coronavirus.

Tuesday’s total of 145,982 people in U.S. hospitals with covid-19, which includes 4,462 children, passed the record of 142,273 set on Jan. 14, 2021, during the previous peak of the pandemic in this country.

But the highly transmissible omicron variant threatens to obliterate that benchmark. If models of omicron’s spread prove accurate — even the researchers who produce them admit forecasts are difficult during a pandemic — current numbers may seem small in just a few weeks. Disease modelers are predicting total hospitalizations in the 275,000 to 300,000 range when the peak is reached, probably later this month.

Hospitalizations increasing to new record high in US and very high usage/demands of medical nitrile gloves very positive news for top 3 Malaysia gloves companies supplying almost 70% nitrile gloves market share in US

Supermax next QR release next month February profits will be badly affected compares to other top 3 glove due to double import ban by US and Canada

Supermax is the most affected gloves company as both US and Canada import ban since October and missing out on very high usage and demands for nitrile gloves due to Omicron variants in US

Pfizer CEO Albert Bourla on Monday said two doses of the company’s vaccine may not provide strong protection against infection from the omicron Covid variant, and the original shots have also lost some of their efficacy at preventing hospitalization.

Bourla, in an interview at J.P. Morgan’s healthcare conference, emphasized the importance of a third shot to boost people’s protection against omicron.

“The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”

Bourla said omicron is a more difficult target than previous variants. Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots.

Pfizer CEO Albert Bourla on Monday said two doses of the company’s vaccine may not provide strong protection against infection from the omicron Covid variant, and the original shots have also lost some of their efficacy at preventing hospitalization.

Bourla, in an interview at J.P. Morgan’s healthcare conference, emphasized the importance of a third shot to boost people’s protection against omicron.

“The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”

Bourla said omicron is a more difficult target than previous variants. Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots.

Omicron variant is definitely not mild and it is just less severe....All US hospitals already reaching to full capacity as peak hospitalizations still few weeks to come

The United States is poised to surpass its record for covid-19 hospitalizations as soon as Tuesday, with no end in sight to skyrocketing case loads, falling staff levels and the struggles of a medical system trying to provide care amid an unprecedented surge of the coronavirus.

Monday’s total of 141,385 people in U.S. hospitals with covid-19 fell just short of the record of 142,273 set on Jan. 14, 2021, during the previous peak of the pandemic in this country.

But the highly transmissible omicron variant threatens to obliterate that benchmark. If models of omicron’s spread prove accurate — even the researchers who produce them admit forecasts are difficult during a pandemic — current numbers may seem small in just a few weeks. Disease modelers are predicting total hospitalizations in the 275,000 to 300,000 range when the peak is reached, probably later this month.

The United States is poised to surpass its record for covid-19 hospitalizations as soon as Tuesday, with no end in sight to skyrocketing case loads, falling staff levels and the struggles of a medical system trying to provide care amid an unprecedented surge of the coronavirus.

Monday’s total of 141,385 people in U.S. hospitals with covid-19 fell just short of the record of 142,273 set on Jan. 14, 2021, during the previous peak of the pandemic in this country.

But the highly transmissible omicron variant threatens to obliterate that benchmark. If models of omicron’s spread prove accurate — even the researchers who produce them admit forecasts are difficult during a pandemic — current numbers may seem small in just a few weeks. Disease modelers are predicting total hospitalizations in the 275,000 to 300,000 range when the peak is reached, probably later this month.

Despite Omicron’s low proportion of severe cases, the sheer number of cases it does cause is proving enough to overwhelm hospitals. In New York, the State Department of Health has ordered 40 hospitals to stop performing non-essential surgeries.

“We will use every available tool to help ensure that hospitals can manage the COVID-19 winter surge,” Acting State Health Commissioner Mary Bassett told WABC.

In Johnson County, Kansas, some filled-up hospitals have told incoming ambulances to go elsewhere, and, with no beds left to offer, have asked emergency room patients to convalesce in waiting rooms. Meanwhile, paramedics work 80-hour weeks and wait for the Omicron wave to crash.

Today Hartalega closing very strong 6.10 and current record high hospitalizations in US really positive news for top 3 Malaysia glove companies to increase supply and grabs more nitrile gloves market share in US from China glove companies under US import tariffs

Top Glove closing green 2.50 and Hartalega the leading nitrile gloves leader in US leads all gloves stocks uptrend rally today closing 25 sen higher to close at 6.10

Supermax can't export to US market since October and their US market share already taken over by other top 3 glove companies and new record high hospitalizations in US has caused very high usage and demands of gloves in US healthcare systems

US new record high hospitalizations last 7 days average 130,000 Covid-19 patients....Worse yet to come for coming few weeks and medical gloves very high usage and demands really good prospects for top 3 Malaysia glove companies....Chinese gloves companies under import tariffs by US will benefit top 3 Malaysia gloves companies increasing glove market share in US